Search - tctmd.com

Displaying 281 - 300 of 390

Sort: Relevancy | Date

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

Presentation BRS 2014

Definition of New Clinical Endpoints: A Report from BRS-ARC

Presenter: Patrick W. Serruys

July 26, 2014

Presentation BRS 2014

BRS Under Development: Differentiated or More of the Same?

Presenter: Patrick W. Serruys

July 26, 2014

Presentation BRS 2014

Theoretical construct: Why BRS may change the landscape of coronary intervention

Presenter: Patrick W. Serruys

July 25, 2014

Presentation BRS 2014

The Landscape of BRS Randomized Trial

Presenter: Patrick W. Serruys

July 25, 2014

Presentation BRS 2014

Is intravascular imaging useful or necessary to optimize BRS results?

Presenter: Patrick W. Serruys

July 25, 2014

Presentation BRS 2014

A Preview to ABSORB II

Presenter: Patrick W. Serruys

July 25, 2014

News Industry News

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

May 23, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

Presentation CIT 2014

Polymeric BRS Are the Way to Go!

Presenter: Patrick W. Serruys

March 20, 2014

Presentation CIT 2014

Addressing the New Enemies: In-BRS Restenosis, Thrombosis, Fractures and Beyond!

Presenter: Patrick W. Serruys

March 20, 2014

Presentation CTO 2014

So Many Risk Models, So Little Time: A Practical Guide to Choosing between CABG and PCI for Left Main Revascularization

Presenter: Patrick W. Serruys

March 01, 2014

Presentation TCT 2013

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Presenter: Patrick Serruys

October 31, 2013

News Conference News TCT 2013

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

October 31, 2013

Presentation TCT 2013

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

Coronary Interventions: Best of EHJ

Presenter: Patrick Serruys

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Presentation TCT 2013

How Useful Are Risk Scores in Selecting Between PCI and CABG?

Presenter: Patrick Serruys

October 29, 2013

Advertisement

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Definition of New Clinical Endpoints: A Report from BRS-ARC

BRS Under Development: Differentiated or More of the Same?

Theoretical construct: Why BRS may change the landscape of coronary intervention

The Landscape of BRS Randomized Trial

Is intravascular imaging useful or necessary to optimize BRS results?

A Preview to ABSORB II

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Polymeric BRS Are the Way to Go!

Addressing the New Enemies: In-BRS Restenosis, Thrombosis, Fractures and Beyond!

So Many Risk Models, So Little Time: A Practical Guide to Choosing between CABG and PCI for Left Main Revascularization

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

Coronary Interventions: Best of EHJ

Two Trials to Assess TAVR in Moderate-Risk Patients

How Useful Are Risk Scores in Selecting Between PCI and CABG?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content